Docetaxel/Ramucirumab Regimen

Preferred Label : Docetaxel/Ramucirumab Regimen;

NCIt synonyms : Ramucirumab/Docetaxel; Cyramza/Docetaxel Regimen; Ramucirumab-Docetaxel; Ramucirumab-Docetaxel Regimen; Ramucirumab/Docetaxel Regimen;

NCIt related terms : Docetaxel and Ramucirumab;

NCIt definition : A regimen consisting of ramucirumab and docetaxel that is used for the treatment of non-small cell lung cancer (NSCLC).;

NCI Metathesaurus CUI : CL523596;

Codes from synonyms : 5678;

Details

Origin ID

C136285;

UMLS CUI

C4526552;

Est indiqué pour
- Locally Advanced Lung Non-Small Cell Carcinoma [NCIt concept]
- Metastatic Lung Non-Small Cell Carcinoma [NCIt concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Docetaxel [NCIt concept]
- Ramucirumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Lung Non-Small Cell Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients